Tissue Engineering or Regnerative Medicine

The term tissue engineering is often synonymous with regenerative medicine. It is basically the use of artificial material constructs, suitable biochemical factors and / or combinations of cells to improve or replace the function of dysfunctional organs. Other uses of tissue engineering are drug efficacy and toxicity testing, and basic research on tissue development (Berthiaume, Maguire, & Yarmush, 2011). Most tissue engineering methods utilize living cells; therefore, it is important to provide reliable cells.

Regenerative Medicine 2019 is concerned about cognitive understanding of new subjects such as stent placement, tissue regeneration, tissue engineering and 3D printing, umbilical cord blood and regenerative medicine, bone and cartilage tissue engineering, stem cells and cancer, tissue bioreactivity It is a high discussion of. , Tissue Chips & Biochip, Immunotherapy, Clinical Medicine etc. This 3 day event will link the science community with the future of organizational science and regenerative medicine. The concept of sharing and applicable knowledge will also promote systematic cooperation to promote scientific acceleration. We are attracting researchers and scientists in tissue engineering, business, creative, technology leaders, and the latest and most relevant marketing.

Regenerative medicine is a field of translation research in tissue engineering and molecular biology, including "replacement of human cells, tissues or organs, engineering or regeneration to restore or establish normal functional processes". In this field, it is expected to design damaged tissues and organs by stimulating the body's own repair mechanism to functionally repair the tissues and organs that could not be repaired previously. Regenerative medicine includes the possibility of culturing tissues and organs in the laboratory and the possibility of transplanting them when the body can not cure itself. If the cells of the regenerating organs are derived from the patient's own tissues or cells, this may solve the problem of organ deficiency available for blood donation as well as the problem of organ transplant rejection.